Funding Update: April 2022

At the beginning of April we received a notice of award of a new NIH R21 grant from NINDS. This is to explore the extent of peripheral nerve disease in CLN1 mice and treat this via gene therapy.

This work will be done together with long term collaborator Mark Sands (Washington University, Medicine) and Alison Snyder-Warwick (Washington University, Surgery).